For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. If you need to see your provider, please contact us to see if a Video Visit is right for you. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.
Feil Family Brain & Mind Research Institute

You are here

Ischemic Stroke in Cancer Patients: A Review of an Underappreciated Pathology.

TitleIschemic Stroke in Cancer Patients: A Review of an Underappreciated Pathology.
Publication TypeJournal Article
Year of Publication2018
AuthorsNavi BB, Iadecola C
JournalAnn Neurol
Date Published2018 Apr 06

Currently one-in-ten patients with ischemic stroke have comorbid cancer and this frequency is expected to increase with continued advances in cancer therapeutics prolonging median survival. Well known for its association with venous thrombosis, cancer has recently emerged as a significant risk factor for arterial thromboembolism including stroke, however, the underlying mechanisms are uncertain. In addition, the optimal strategies to prevent and acutely treat stroke in cancer patients is yet to be established. This review summarizes the current evidence on ischemic stroke risk, biomarkers, pathophysiology, treatments, and prognosis in cancer patients, emphasizing knowledge gaps and the potential strategies to address them. This article is protected by copyright. All rights reserved.

Alternate JournalAnn. Neurol.
PubMed ID29633334